FDA clears new treatment for invasive aspergillosis.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000666:Amphotericin B / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D001228:Aspergillosis / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000935:Antifungal Agents; D000666:Amphotericin B